A broad atlas of somatic hypermutation allows prediction of activation-induced deaminase targets
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Activation-induced deaminase (AID) initiates antibody diversification in germinal center (GC) B cells through the deamination of cytosines on immunoglobulin genes. AID can also target other regions in the genome, triggering mutations or chromosome translocations, with major implications for oncogenic transformation. However, understanding the specificity of AID has proved extremely challenging. We have sequenced at very high depth >1,500 genomic regions from GC B cells and identified 275 genes targeted by AID, including 30 of the previously known 35 AID targets. We have also identified the most highly mutated hotspot for AID activity described to date. Furthermore, integrative analysis of the molecular features of mutated genes coupled to machine learning has produced a powerful predictive tool for AID targets. We also have found that base excision repair and mismatch repair back up each other to faithfully repair AID-induced lesions. Finally, our data establish a novel link between AID mutagenic activity and lymphomagenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, the TSS regions of MM driver genes, known as AID targets69, have a significantly stronger DRIP-seq signal compared to the average of all active genes in B lymphocytes (Supplementary Fig. S6f).”
From DIS3 mutations enhance AID-driven translocations during B-cell activation, promoting transformation to multiple myeloma (2026) · cites this paper as [69]
In the citing paper
“Indeed, regions involved in structural chromosomal aberrations in our plasmacytoma samples show a level of DRIP-seq accumulation (Fig. 4h–j, Supplementary Fig. S6a–e) like AID off-target loci (Fig. 4h)69.”
From DIS3 mutations enhance AID-driven translocations during B-cell activation, promoting transformation to multiple myeloma (2026) · cites this paper as [69]
In the citing paper
“Further analysis of genomic regions encompassing known AID-dependent MM driver genes69 where mutations are under positive selection pressure during the carcinogenesis revealed a very strong overrepresentation of signatures related to both AID-dependent mutagenesis and defects in the repair of DNA lesions typical for CSR and SHM (namely: BER SBS10b, SBS30, and MMR SBS6, SBS26) (Fig. 5f, g).”
From DIS3 mutations enhance AID-driven translocations during B-cell activation, promoting transformation to multiple myeloma (2026) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas
Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R. S. K., Küppers, R., & Dalla-Favera, R. (2001) · Nature · doi:10.1038/35085588 · Cited by 1,032
Orientation-specific joining of AID-initiated DNA breaks promotes antibody class switching
Dong, J., Panchakshari, R. A., Zhang, T., Zhang, Y., Hu, J., Volpi, S. A., Meyers, R. M., Ho, Y.-J., Du, Z., Robbiani, D. F., et al. (2015) · Nature · doi:10.1038/nature14970 · Cited by 123 · cited 6×
“However, genome-wide AID specificity has been inferred from high-throughput analysis of AID binding, which does not warrant AID activity, AID-induced DSBs, or chromosomal TCs, which involve complex processing of the initial lesion induced by AID (Chiarle et al., 2011; Klein et al., 2011; Staszewski et al., 2011; Yaman…”
Influential
Research works printed but not linked: 44
- Chiarle, 2011, Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells, Cell., 147, 107, 10.1016/j.cell.2011.07.049 · DOI · Paper page
- de Miranda, 2014, Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients, Blood., 124, 2544, 10.1182/blood-2013-12-546309 · DOI · Paper page
- Di Noia, 2007, Molecular mechanisms of antibody somatic hypermutation, Annu. Rev. Biochem., 76, 1, 10.1146/annurev.biochem.76.061705.090740 · DOI · Paper page
- Feng, 2011, Using MACS to identify peaks from ChIP-Seq data, Curr. Protoc. Bioinformatics., 2, 14
- Frey, 1998, Mismatch repair deficiency interferes with the accumulation of mutations in chronically stimulated B cells and not with the hypermutation process, Immunity., 9, 127, 10.1016/S1074-7613(00)80594-4 · DOI
- Gordon, 2003, Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a), Proc. Natl. Acad. Sci. USA., 100, 4126, 10.1073/pnas.0735266100 · DOI
- Klein, 2011, Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes, Cell., 147, 95, 10.1016/j.cell.2011.07.048 · DOI · Paper page
- Liu, 2008, Two levels of protection for the B cell genome during somatic hypermutation, Nature., 451, 841, 10.1038/nature06547 · DOI · Paper page
- Lohr, 2012, Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing, Proc. Natl. Acad. Sci. USA., 109, 3879, 10.1073/pnas.1121343109 · DOI · Paper page
- Love, 2012, The genetic landscape of mutations in Burkitt lymphoma, Nat. Genet., 44, 1321, 10.1038/ng.2468 · DOI · Paper page
- Meng, 2014, Convergent transcription at intragenic super-enhancers targets AID-initiated genomic instability, Cell., 159, 1538, 10.1016/j.cell.2014.11.014 · DOI · Paper page
- Methot, 2017, Molecular Mechanisms of Somatic Hypermutation and Class Switch Recombination, Adv. Immunol., 133, 37, 10.1016/bs.ai.2016.11.002 · DOI · Paper page
- Morin, 2013, Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing, Blood., 122, 1256, 10.1182/blood-2013-02-483727 · DOI · Paper page
- Muramatsu, 2000, Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme, Cell., 102, 553, 10.1016/S0092-8674(00)00078-7 · DOI · Paper page
- Müschen, 2000, Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction, J. Exp. Med., 192, 1833, 10.1084/jem.192.12.1833 · DOI · Paper page
- Nambu, 2003, Transcription-coupled events associating with immunoglobulin switch region chromatin, Science., 302, 2137, 10.1126/science.1092481 · DOI
- Nilsen, 2000, Uracil-DNA glycosylase (UNG)-deficient mice reveal a primary role of the enzyme during DNA replication, Mol. Cell., 5, 1059, 10.1016/S1097-2765(00)80271-3 · DOI · Paper page
- Okosun, 2014, Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma, Nat. Genet., 46, 176, 10.1038/ng.2856 · DOI · Paper page
- Pavri, 2010, Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5, Cell., 143, 122, 10.1016/j.cell.2010.09.017 · DOI · Paper page
- Pérez-Durán, 2012, UNG shapes the specificity of AID-induced somatic hypermutation, J. Exp. Med., 209, 1379, 10.1084/jem.20112253 · DOI · Paper page
- Petersen-Mahrt, 2002, AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification, Nature., 418, 99, 10.1038/nature00862 · DOI · Paper page
- Phung, 1998, Increased hypermutation at G and C nucleotides in immunoglobulin variable genes from mice deficient in the MSH2 mismatch repair protein, J. Exp. Med., 187, 1745, 10.1084/jem.187.11.1745 · DOI · Paper page
- Qian, 2014, B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity, Cell., 159, 1524, 10.1016/j.cell.2014.11.013 · DOI · Paper page
- Rada, 1998, Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting, Immunity., 9, 135, 10.1016/S1074-7613(00)80595-6 · DOI · Paper page
- Rada, 2002, Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice, Curr. Biol., 12, 1748, 10.1016/S0960-9822(02)01215-0 · DOI · Paper page
- Rada, 2004, Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation, Mol. Cell., 16, 163, 10.1016/j.molcel.2004.10.011 · DOI · Paper page
- Ramiro, 2004, AID is required for c-myc/IgH chromosome translocations in vivo, Cell., 118, 431, 10.1016/j.cell.2004.08.006 · DOI · Paper page
- Ramiro, 2006, Role of genomic instability and p53 in AID-induced c-myc-Igh translocations, Nature., 440, 105, 10.1038/nature04495 · DOI · Paper page
- Reitmair, 1995, MSH2 deficient mice are viable and susceptible to lymphoid tumours, Nat. Genet., 11, 64, 10.1038/ng0995-64 · DOI · Paper page
- Revy, 2000, Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2), Cell., 102, 565, 10.1016/S0092-8674(00)00079-9 · DOI · Paper page
- Reynaud, 2009, Competitive repair pathways in immunoglobulin gene hypermutation, Philos. Trans. R. Soc. Lond. B Biol. Sci., 364, 613, 10.1098/rstb.2008.0206 · DOI
- Robbiani, 2008, AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations, Cell., 135, 1028, 10.1016/j.cell.2008.09.062 · DOI · Paper page
- Robbiani, 2009, AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations, Mol. Cell., 36, 631, 10.1016/j.molcel.2009.11.007 · DOI · Paper page
- Rogozin, 1992, Somatic hypermutagenesis in immunoglobulin genes: II. Influence of neighbouring base sequences on mutagenesis, Biochim. Biophys. Acta., 1171, 11, 10.1016/0167-4781(92)90134-L · DOI · Paper page
- Shaffer, 2012, Pathogenesis of human B cell lymphomas, Annu. Rev. Immunol., 30, 565, 10.1146/annurev-immunol-020711-075027 · DOI · Paper page
- Shen, 1998, Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes, Science., 280, 1750, 10.1126/science.280.5370.1750 · DOI · Paper page
- Staszewski, 2011, Activation-induced cytidine deaminase induces reproducible DNA breaks at many non-Ig Loci in activated B cells, Mol. Cell., 41, 232, 10.1016/j.molcel.2011.01.007 · DOI
- Stavnezer, 2008, Mechanism and regulation of class switch recombination, Annu. Rev. Immunol., 26, 261, 10.1146/annurev.immunol.26.021607.090248 · DOI · Paper page
- Storb, 2014, Why does somatic hypermutation by AID require transcription of its target genes?, Adv. Immunol., 122, 253, 10.1016/B978-0-12-800267-4.00007-9 · DOI
- Wang, 2014, Epigenetic targeting of activation-induced cytidine deaminase, Proc. Natl. Acad. Sci. USA., 111, 18667, 10.1073/pnas.1420575111 · DOI
- Wei, 2015, Overlapping hotspots in CDRs are critical sites for V region diversification, Proc. Natl. Acad. Sci. USA., 112, E728, 10.1073/pnas.1500788112 · DOI
- Yamane, 2011, Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes, Nat. Immunol., 12, 62, 10.1038/ni.1964 · DOI · Paper page
- Yeap, 2015, Sequence-Intrinsic Mechanisms that Target AID Mutational Outcomes on Antibody Genes, Cell., 163, 1124, 10.1016/j.cell.2015.10.042 · DOI · Paper page
- Zhang, 2013, Genetic heterogeneity of diffuse large B-cell lymphoma, Proc. Natl. Acad. Sci. USA., 110, 1398, 10.1073/pnas.1205299110 · DOI · Paper page
Cited by
Epithelial–immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis
Verstappen, G. M., Pringle, S., Bootsma, H., & Kroese, F. G. M. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00605-2 · Cited by 298
Diverse mutational landscapes in human lymphocytes
Machado, H. E., Mitchell, E., Øbro, N. F., Kübler, K., Davies, M., Leongamornlert, D., Cull, A., Maura, F., Sanders, M. A., Cagan, A. T. J., et al. (2022) · Nature · doi:10.1038/s41586-022-05072-7 · Cited by 116
Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma
Maura, F., Rustad, E. H., Yellapantula, V., Łuksza, M., Hoyos, D., Maclachlan, K. H., Diamond, B. T., Greenbaum, B. D., Morgan, G., Lesokhin, A., et al. (2020) · Leukemia · doi:10.1038/s41375-019-0689-0 · Cited by 50
Kuliński, T. M., Gewartowska, O., Mahé, M., Kasztelan, K., Durys, N., Stroynowska-Czerwińska, A., Jedynak-Slyvka, M., Owczarek, E. P., Chaudhury, D., Nowotny, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70386-3 · Cited by 7
Metadata
- Authors
- Álvarez-Prado, Á. F., Pérez-Durán, P., Pérez-García, A., Benguria, A., Torroja, C., de Yébenes, V. G., & Ramiro, A. R.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2018-01-26
- Volume
- 215
- Issue
- 3
- Pages
- 761-771
- ISSN
- 0022-1007
- 1540-9538
- Cited by
- 111
- References
- 2
- Language
- en
- Funders
- Ministerio de Educación, Cultura y Deporte (FPU-AP2009-1732)
- Centro Nacional de Investigaciones Cardiovasculares Carlos III
- Ministerio de Economía, Industria y Competitividad (SAF2013-42767-R, SAF2016-75511-R)
- Fondo Europeo de Desarrollo Regional
- European Research Council (BCLYM-207844)
- MEIC (SEV-2015-0505)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.